Pharmafile Logo

McCann Health Engagement

As a media agency exclusively focused on healthcare, McCann Health Engagement has deep knowledge and vast experience planning and buying in the pharmaceutical industry specific to HCP and DTC on a global scale. We have experience working on almost every therapeutic category within the healthcare and pharmaceutical landscape.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

CMI Media Group

CMI Media Group, a WPP company, is a full-service media agency focused solely on health, wellness, and pharmaceutical marketing. CMI Media Group’s core offerings include Audience Strategy, Planning, Development, and…

View Profile

Four Agency Worldwide

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with content creators, PR gurus with advertising geniuses & sector specialists…

View Profile

Havas Lynx

We are the Havas Lynx. Devoted to fresh thinking. Changing the way the world does healthcare communications for the better. Great talent. Great ideas. Great outcomes.

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

Company Details

7-11 Herbrand St, London, WC1N 1AF, UK

 Latest Content from PMHub 

Data-driven policy and market access firm Avalere joins Fishawack Health

Press Releases | June 16, 2022 | Avalere Health

Fishawack Health bolsters its commercialization service offering with its largest addition to date, welcoming US-based policy, market access, and transformation leader Avalere.

Cuttsy+Cuttsy gain highly regarded PIF Partner status

As official PIF Partners, Cuttsy+Cuttsy will be supporting the Patient Information Forum raise awareness of the PIF TICK.

Science for science sake

Like great works of art, there was no ‘reason’ for certain scientific endeavours, but this ‘just for the sake of it’ philosophy is now delivering tangible benefits. (article written 3rd...

Embrace mental health first aiders for better work wellbeing

Mental health first aid can work as a vital steppingstone to instilling good mental health practices into wider company culture and ensure everyone knows what to be looking out for...

Celebrating World Blood Donor Day

Each 14th June World Blood Donor day is celebrated around the world to spread awareness around the importance of giving blood.

Spending on anti-depressants soars as the pandemic’s effect on NHS prescribing patterns is revealed

Wilmington Healthcare’s State of the Nation prescribing report shows that spending on sertraline, commonly used to treat depression and anxiety, increased by 305.5% between 2019/20 and 2020/21 while overall spend...

Accelerating patient recruitment in clinical trials post COVID-19

Patient recruitment is arguably one of the most important aspects of a clinical trial. Without enough participants, trials will inevitably fail, meaning potentially effective therapies will not be brought to...

Diversity in Clinical Trials: A more inclusive approach in patient recruitment

We have seen a growing focus on patient diversity in clinical trials in recent years, but the COVID-19 vaccine trials in particular have highlighted the importance of achieving diverse patient...

Part 4 of 4, of the Medscape video interview series

Dr. Hansa Bhargava MD interviews Dr. Maria Victoria Mateos on the most important abstracts to look out for in multiple myeloma and the potential implications of these data for managing patients...

How whole genome sequencing is revolutionising the rare disease patient experience

In this white paper, we discuss how whole genome sequencing (WGS) projects and the data sets they produce are paving the way for developments in research, diagnosis, and early interventions...